[1]
C. Pivadga, E. P. Odum, and B. A. A.- Hart, “Hydroxyurea Dose Escalation to Maximum Tolerated Dose in Pediatric Sickle Cell Disease: Hematologic and Clinical Outcomes in a Resource-Limited Setting in Cameroon. A Quasi-Experimental Study”., SJHR-Africa, vol. 7, no. 3, p. 10, Mar. 2026, doi: 10.51168/6zd3jy11.